T
Taj For DoctorsTaj Doctor
home

About Us

Taj Brands

Diseases Health Tips  HIV/AIDS News Contact Us

 

  All News
  Allergy
  Asthma
  Cardiology
  Clinical Research
  Critical Care
  Dentistry
  Dermatology
  Endocrinology
  Gastroenterology
  General
  Genetics / Biotech
  Men's Health
  Infectious Diseases
  Fitness/Lifestyle
  Nephrology
  Neurology
  Oncology/Haematology
  Ophthalmology
  Orthopaedics
  Otolaryngology
  Paediatrics
  Psychiatry
  Reproductive Health
  Respiratory Medicine
  Surgery
  Sex
  Urology
  Women's Health
Taj Brands


Therapeutic Index

Dopin TM
Composition

Dopin Tablets
Each tablet contains
Dothiepin hydrochloride 5mg

Indications

Depression. Anxiety associated with depression.

Dosage and Administration

Adults: Initially 75mg daily in divided doses or as a single dose at night. Increasing to 150 mg with caution & under close supervision. Maintanence: 150 mg as a single dose at night. Children: Not recommended.

Interactions
Anticholinergics: Enhanced effect of anticholinergics may occur. Barbiturates: Serum level of imipramine decreased; additive respiratory depressant effect. Clonidine: Hypertensive crisis. Dicoumarol: Increase in anticoagulation effects. Disulfiram: Acute organic brain syndrome. Fluoxetine & Haloperidol: Potentiate action of imipramine. Levodopa: Its bioavailability is reduced, hypertensive episodes. MAOIs, Furazolidone: Seizures, sweating, coma, hyperexcitability, hyperthermia, tachycardia, mydriasis, confusion, DIC. (Disseminated Intravascular Coagulation) and death. Oral Contraceptives and Phenothiazines: Increase plasma levels of imipramine. Smoking: Increases metabolic bio-transformation. Alcohol: Sedative effect of alcohol potentiated.

W
arnings and precautions:
Should be take by on the prescription of a registered medical practitioner only.


Presentation:

Dopin                                         Blister pack of 30 tablets

 
 

         Copyright 2004- 2006 TAJ Pharmaceuticals Limited. All Rights Reserved.

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

Terms and Conditions | Disclaimer | Privacy Policy | Sitemap | Feedback | FAQ